“I saw the difference it was making in his life, his thinking and his behavior,” Sinema told Phoenix New Times ... based organization or research agency to host clinical trials of ibogaine ...

Self-described female-founded oncology company Phoenix Molecular Designs has started dosing in the Phase II arm of a trial examining its metastatic breast cancer candidate, PMD-026. The Phase I/Ib ...

Arizona State University announced on Monday the location of where its future state-of-the-art medical school will be built.

Self-described female-founded oncology company Phoenix Molecular Designs ... stages of the study across eight clinical sites across the US. The Dauntless-1 trial aims to extend the impact of ...